Serum institute banned from exporting Oxford-AstraZeneca's COVID-19 vaccine for several months: Adar Poonawalla
4 years ago

Serum institute banned from exporting Oxford-AstraZeneca's COVID-19 vaccine for several months: Adar Poonawalla

Firstpost  

He said the vaccine can only be given to the Indian government and export of vaccines for COVAX, won’t begin until March or April. India will not allow the export of the Oxford University-AstraZeneca coronavirus vaccine for several months, the head of Serum Institute of India, which has been contracted to make one billion doses of the vaccine for developing nations, said Sunday. The vaccine was granted emergency authorization by the Indian regulator on Sunday, but on the condition that Serum Institute doesn’t export the shots to ensure that vulnerable populations in India are protected, Adar Poonawalla, the company’s CEO, said in a phone interview with The Associated Press. Poonawalla said that Serum Institute was in the process of signing a larger contract with COVAX for 300 million-400 million doses of the vaccine. He said the first 100 million doses of the vaccine were being sold to the Indian government at a “special price” of 200 rupees per dose, after which prices would be higher.

India Indian Vaccines Million Institute Export Vaccine Oxford Serum Poonawalla Serum Institute Months Adar  covax  india  doses  institute  vaccines  million  vaccine  months  adar  export  indian  oxfordastrazenecas  serum  poonawalla  banned  exporting  covid19

History of this topic

Serum Institute to manufacture Mpox vaccine by Danish maker Bavarian Nordic
Trending News
3 weeks, 3 days ago

Serum Institute to manufacture Mpox vaccine by Danish maker Bavarian Nordic

Hindustan Times  

Pune-based Serum Institute of India will be manufacturing Danish vaccine company Bavarian Nordic’s vaccine against mpox— MVA-BN— locally for the Indian market, according to latter’s statement issued on Monday on the license and manufacturing agreement signed between the two companies. “… Under the agreement, the companies will undertake a technology transfer of the current manufacturing process for MVA-BN® to SII …

Milestone in malaria battle as £3 vaccine is rolled out across Africa which could eradicate killer, mosquito-borne illness within 10 years
5 months, 3 weeks ago

Milestone in malaria battle as £3 vaccine is rolled out across Africa which could eradicate killer, mosquito-borne illness within 10 years

Daily Mail  

African babies are set to receive a £3 malaria vaccine that could potentially eradicate the disease within a decade. African babies will receive a £3 malaria vaccine that could eradicate malaria within a decade The first doses of the R21 jab, developed by a team at the University of Oxford, will be given to babies under the age of two …

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
7 months, 4 weeks ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
8 months ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
8 months ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

Stopped manufacturing Covishield since December 2021, says Serum Institute
8 months ago

Stopped manufacturing Covishield since December 2021, says Serum Institute

Hindustan Times  

Pune-based Serum Institute of India stopped manufacturing its anti-Covid-19 vaccine Covishield in 2021, according to a statement issued by the company on Wednesday after British-Swedish pharmaceutical manufacturer AstraZeneca announced it was withdrawing its vaccine against Covid, Vaxzevria, due to “commercial reasons” as demand for it decreased globally. Consequently, since December 2021, we have stopped the manufacturing and supply of additional …

AstraZeneca pulls its COVID-19 vaccine from the European market
8 months ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
8 months ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
8 months ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

EU countries destroyed €4 billion worth of Covid-19 vaccines, reveals research
1 year ago

EU countries destroyed €4 billion worth of Covid-19 vaccines, reveals research

Firstpost  

Governments, including the EU’s second-most populous country France, have been reluctant to reveal the scale of the waste, but it is certain that most EU nations have resorted to wasting doses of the Covid-19 vaccine, once a much sought after commodity Nearly 215 million doses of Covid-19 vaccines purchased by EU countries at the height of the pandemic have since …

Oxford-Serum institute malaria vaccine recommended for use by WHO
1 year, 3 months ago

Oxford-Serum institute malaria vaccine recommended for use by WHO

The Hindu  

The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant technology, has been recommended for use by the World Health Organisation after meeting required safety, quality and effectiveness standards, on Monday. According to information released by the Serum Institute, the WHO recommendation was based on pre-clinical and clinical trial data which …

Serum Institute of India to produce 5mn Covishield doses in two months
1 year, 8 months ago

Serum Institute of India to produce 5mn Covishield doses in two months

Hindustan Times  

Serum Institute of India chief executive officer Adar Poonawalla, while underlining that the current strain of Covid is mild and the demand for vaccine shots is low, said his firm will produce five to six million Covishield doses in the next two to three months and same amount of stock is already available for Covovax. According to Poonawalla, SII has …

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses
2 years ago

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses

News 18  

Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of Covid-19 vaccines ready to dispatch as and when orders are received. According to respective company sources, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
2 years ago

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses

India TV News  

As Covid cases are increasing in the country, now focus is back on vaccination drive. According to sources- two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together have about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. Corbevax and Covaxin stocks Biological E held 200 million doses of its …

GAVI financing to allow for immediate funds for next pandemic
2 years, 3 months ago

GAVI financing to allow for immediate funds for next pandemic

Live Mint  

Global vaccine alliance GAVI has set up financial instruments that will allow the group to immediately access pledged donor funding if it needs to buy vaccines for future pandemics, Chief Executive Seth Berkley told Reuters. Berkley said that in 2020 and 2021, GAVI was limited in its ability to buy COVID-19 vaccines because even though donors had committed $2.4 billion, …

Serum institute prepares to import Monkeypox vaccine in India amid global worry
2 years, 5 months ago

Serum institute prepares to import Monkeypox vaccine in India amid global worry

Live Mint  

With India having reported four Monkeypox cases so far, the Serum Institute of India has said that it is negotiating the import of a small of the vaccine with the Danish firm Bavarian Nordic, reported PTI. Quoting SII CEO Adar Poonawalla, the news agency stated in case of a collaboration, it may take two to three months to get the …

Serum Institute gets govt nod to export 32.4 lakh doses of Covovax vaccine to US
2 years, 6 months ago

Serum Institute gets govt nod to export 32.4 lakh doses of Covovax vaccine to US

India Today  

The government has allowed Serum Institute of India to supply 32.4 lakh doses of its Covid-19 jab Covovax under the brand name Nuvaxovid to the US, which will be the first vaccine to be exported to the country by any Indian manufacturer, official sources said on Friday. "It is a matter of pride for us and our country that, in …

Adar Poonawalla’s Pitch for Pandemic Treaty at Davos, Says Might Have to Destroy Covid Jab Doses
2 years, 7 months ago

Adar Poonawalla’s Pitch for Pandemic Treaty at Davos, Says Might Have to Destroy Covid Jab Doses

News 18  

Serum Institute of India chief executive officer Adar Poonawalla, in an interview to Shereen Bhan of CNBC-TV18, on Monday said he is advocating a global pandemic treaty, and has proposed that there should be a framework for leaders to work with. Stressing that there is an “oversupply” of Covid-19 vaccines in the world, Poonawalla, on the sidelines of the World …

Africa's COVID vaccine production line in jeopardy
2 years, 7 months ago

Africa's COVID vaccine production line in jeopardy

The Hindu  

Trisha shakes her head when asked if she's vaccinated. 'A massive setback for Africa's plans' In the absence of orders or commitments, Aspen is considering the repurposing of two COVID-19 production lines for the manufacture of other products. "The continent would lose its only existing COVID vaccine manufacturing capacity," Nicolaou says. Africa's major public health body, the Africa Centers for …

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO
2 years, 8 months ago

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO

Hindustan Times  

Chief executive officer of Serum Institute of India Adar Poonawalla on Tuesday said the company has a stockpile of 200 million doses of Covishield, while it has already exported 40 million doses of Covovax to European countries and Australia. Serum Institute of India CEO Adar Poonawalla speaks at the 'AIMA Leadership Conclave' in New Delhi on Tuesday, "We have a …

WHO suspends international supply of Covaxin via UN procurement
2 years, 9 months ago

WHO suspends international supply of Covaxin via UN procurement

India Today  

The World Health Organization in a statement issued on April 2 confirmed the suspension of supply of Covaxin produced by Bharat Biotech, through UN procurement agencies and gave recommendation to the countries that received the vaccine to take actions as appropriate. On April 1, the Indian vaccine manufacturer Bharat Biotech issued a statement announcing the “temporary slowing down of Covaxin …

Rich countries getting new COVID vaccine before poorer ones despite U.N.-backed initiative
2 years, 9 months ago

Rich countries getting new COVID vaccine before poorer ones despite U.N.-backed initiative

LA Times  

A worker moves boxes carrying Novavax’s COVID-19 vaccine at SK Bioscience Co. in Andong, South Korea, on Feb. 9. Novavax, the company behind a COVID-19 vaccine touted as a key tool for the developing world, will miss a target for giving doses to a U.N.-backed effort to supply shots to poorer countries. The company behind a COVID-19 vaccine touted as …

Rich Countries Getting New COVID Vaccine Before Poorer Ones
2 years, 9 months ago

Rich Countries Getting New COVID Vaccine Before Poorer Ones

Huff Post  

FILE - A worker moves boxes carrying Novavax's COVID-19 vaccine at SK Bioscience Co. in Andong, South Korea, on Feb. 9, 2022. via Associated Press NEW DELHI — The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed …

Rich countries getting new COVID vaccine before poorer ones
2 years, 9 months ago

Rich countries getting new COVID vaccine before poorer ones

Associated Press  

NEW DELHI — The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic. The company, Novavax, got $388 million from one …

Rich countries getting new Novavax COVID-19 vaccine before poorer ones
2 years, 9 months ago

Rich countries getting new Novavax COVID-19 vaccine before poorer ones

LA Times  

The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the United Nations-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic. The investment guaranteed COVAX the “right of first refusal” to …

Corbevax safe for kids, offers high antibody levels, says Biological E CEO | EXCLUSIVE
2 years, 9 months ago

Corbevax safe for kids, offers high antibody levels, says Biological E CEO | EXCLUSIVE

India Today  

India's third homegrown Covid-19 vaccine, Corbevax, is safe and offers good immunogenicity and higher antibody levels than some other vector vaccines, said Mahima Datla, managing director of Biological E. Limited on Wednesday. THE CORBEVAX CONTROVERSY Asked how effective the vaccine will be against Omicron, the latest strain to emerge which drove the third wave in, Datla said it was a …

Panel pitches full market nod for Covaxin, Covishield
2 years, 11 months ago

Panel pitches full market nod for Covaxin, Covishield

Hindustan Times  

The subject expert panel of the national drugs regulator on Wednesday recommended full market authorisation for both Covaxin and Covishield under certain conditions, according to people familiar with the developments. Serum Institute of India and Bharat Biotech International Ltd, manufacturers of Covishield and Covaxin respectively, separately applied to the central drugs standard control organisation to seek full market authorisation stating …

Poorer nations reject over 100 million Covid shots as many close to expiry
2 years, 11 months ago

Poorer nations reject over 100 million Covid shots as many close to expiry

India Today  

Poorer nations last month rejected more than 100 million doses of Covid-19 vaccines distributed by the global programme COVAX, mainly due to their rapid expiry date, a UNICEF official said on Thursday. UNICEF's data on supplies and use of delivered vaccines show that 681 million shipped doses are currently stored in about 90 poorer nations, according to CARE, a charity, …

Gavi and Bharat Biotech discuss possible COVAX use of Covaxin
3 years ago

Gavi and Bharat Biotech discuss possible COVAX use of Covaxin

Live Mint  

The Gavi vaccine alliance is in talks with India's Bharat Biotech over potential procurement of the company's Covaxin COVID-19 shot for the COVAX global vaccine distribution programme, a Gavi spokesperson told Reuters on Thursday. The World Health Organization in November gave Covaxin, India's first homegrown COVID-19 vaccine, approval for emergency use. Gavi said it was also working with the Serum …

UK Marks First Anniversary of Oxford-AstraZeneca Covid-19 Vaccine Deployment
3 years ago

UK Marks First Anniversary of Oxford-AstraZeneca Covid-19 Vaccine Deployment

News 18  

The UK's health service on Tuesday marked the first anniversary of the deployment of the Oxford/AstraZeneca vaccine against COVID-19, manufactured and deployed in India soon after as Covishield. "Backed by government funding, the UK-made Oxford-AstraZeneca vaccine has played an absolutely crucial role in our fight against COVID-19, saving countless lives in the UK and around the world," said UK Health …

Give full authorisation to Covishield: Serum Institute of India
3 years ago

Give full authorisation to Covishield: Serum Institute of India

Hindustan Times  

NEW DELHI: Pune-based Serum Institute of India on Friday announced it has applied to India’s drugs regulator for full market authorisation to Covishield, its anti-Covid vaccine, citing adequate availability of the required data. The government of India now has enough data for full market authorisation, and therefore @SerumInstIndia has applied to the @CDSCO_INDIA_INF and @MoHFW_INDIA for this permission,” Adar Poonawalla, …

Serum Institute of India applies to Indian authorities for full market authorisation of Covishield
3 years ago

Serum Institute of India applies to Indian authorities for full market authorisation of Covishield

Firstpost  

SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine to the Indian government, which had in January this year granted emergency use authorisation in the country. New Delhi: Serum Institute of India CEO Adar Poonawala on Friday said the vaccines major has applied to Indian authorities for full market authorisation of Covishield, stating supplies …

Covishield could soon be available at medical stores as SII seeks full market authorisation nod
3 years ago

Covishield could soon be available at medical stores as SII seeks full market authorisation nod

India TV News  

Pune-based Serum Institute of India has applied for full market authorisation for the COVID-19 vaccine Covishield with the drug regulator. SII CEO Adar Poonawala confirmed that the institute has applied for full market authorisation of the drug, stating supplies of the COVID-19 vaccine have exceeded 125 crore doses. The institute had earlier this month sought the drug regulator's approval for …

Govt allows export of 7 crore Covovax vaccine doses to Netherlands, Australia, New Zealand
3 years ago

Govt allows export of 7 crore Covovax vaccine doses to Netherlands, Australia, New Zealand

India Today  

The Indian government has permitted the export of 7 crore doses of COVID-19 vaccine ‘Covovax’ produced by Serum Institute of India here to Netherlands, Australia and New Zealand, official sources said on Wednesday. Director, Government and Regulatory Affairs at Serum Institute of India, Prakash Kumar Singh had submitted an application to the Drugs Controller General of India, seeking no objection …

Biological E Aims to Produce 100 Mn Doses/month of Corbevax from Feb 2022
3 years ago

Biological E Aims to Produce 100 Mn Doses/month of Corbevax from Feb 2022

News 18  

Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the city-based company to deliver 300 Million doses as promised to the Centre, BE said on Tuesday. “Biological E. Limited plans to complete production at a …

Covovax Approval to Strengthen Immunization Efforts in India, Lower, Middle Income Countries: SII
3 years ago

Covovax Approval to Strengthen Immunization Efforts in India, Lower, Middle Income Countries: SII

News 18  

Vaccine major Serum Institute of India on Tuesday said the approval for the COVID-19 vaccine 'Covovax' would strengthen immunization initiatives across India and various lower and middle income countries across the world. He was responding to Union Health Minister Mansukh Mandaviya's announcement that the Central Drug Authority, the Central Drugs Standard Control Organisation, has approved the SII's vaccine Covovax for …

Expert panel recommends emergency nod for Serum Institute's Covid vaccine Covovax
3 years ago

Expert panel recommends emergency nod for Serum Institute's Covid vaccine Covovax

India Today  

An expert panel of the country’s central drug authority has recommended granting emergency use authorisation to Serum Institute of India's Covid-19 vaccine ‘Covovax’ with certain conditions, official sources said on Monday. Prakash Kumar Singh, director, Government and Regulatory Affairs at Serum Institute of India had submitted an application to the Drugs Controller General of India in October for grant of …

Serum Institute-Novavax's anti-COVID vaccine gets emergency use listing from WHO
3 years ago

Serum Institute-Novavax's anti-COVID vaccine gets emergency use listing from WHO

Firstpost  

Adar Poonawalla, the CEO of Serum Institute of India, hailed WHO’s decision as “yet another milestone” in the fight against COVID-19. New Delhi: The World Health Organisation on Friday issued emergency use listing for anti-COVID vaccine Covovax produced by Serum Institute of India under licence from Novavax, expanding the basket of jabs validated by the global health body against the …

Serum Institute-Novovax's Covid Vaccine Covovax Gets Emergency Use Listing from WHO
3 years ago

Serum Institute-Novovax's Covid Vaccine Covovax Gets Emergency Use Listing from WHO

News 18  

The World Health Organisation on Friday issued emergency use listing for anti-COVID vaccine Covovax produced by Serum Institute of India under licence from Novavax, expanding the basket of jabs validated by the global health body against the viral disease. According to WHO, Covovax was assessed under its emergency use listing procedure based on the review of data on quality, safety …

WHO approves Serum Institute's Covovax for emergency approval
3 years ago

WHO approves Serum Institute's Covovax for emergency approval

Op India  

The World Health Organisation on Friday approved the emergency use for Serum Institute of India’s Covovax, vaccine developed by the Serum Institute of India in partnership with the US-based Novavax, for showing excellent safety and efficacy. With this approval, Covovax became the 9th Covid-19 vaccine to be permitted for emergency use, providing a boost to ongoing efforts to vaccinate more …

Israel to donate 1 million vaccine doses to African countries
3 years ago

Israel to donate 1 million vaccine doses to African countries

India Today  

In the coming weeks, the State of Israel will distribute one million AstraZeneca Covid-19 vaccines to African countries through the International Covax Vaccine Distribution Mechanism. While Corona vaccines aren’t distributed across the entire world in order to defeat the pandemic, new Corona variants will develop in areas where vaccination rates are low," Israel foreign minister Yair Lapid said. Covax is …

Vaccine maker SII pledges $66 million to Oxford University
3 years ago

Vaccine maker SII pledges $66 million to Oxford University

Hindustan Times  

Vaccine maker Serum Institute of India has pledged 50 million pounds to the University of Oxford for setting up a research campus that would also house the institute behind the AstraZeneca-Oxford COVID-19 shot. The pledge builds on the collaboration between Oxford University, AstraZeneca and SII The investment was made through the Indian company's Serum Life Sciences unit, Oxford University said …

Variants, boosters turn rich-poor vaccine gap into chasm
3 years, 1 month ago

Variants, boosters turn rich-poor vaccine gap into chasm

Associated Press  

PARIS — The global initiative to share coronavirus vaccines fairly already scaled back its pledge to the world’s poor once. Now, to meet even that limited promise, COVAX would have to deliver more than a million doses every hour until the end of the year in some of the world’s most challenging places. COVAX’s new promise is for 1.4 billion …

India’s Serum Institute resumes vaccine exports to COVAX
3 years, 1 month ago

India’s Serum Institute resumes vaccine exports to COVAX

Al Jazeera  

The world’s largest vaccine maker halted shipments of COVID shots in March as India saw an explosion in infections. The Serum Institute of India, the world’s largest vaccine maker, has resumed exports of coronavirus vaccines to the UN-backed COVAX distribution programme after halting most overseas sales in March. At the time, Serum Institute had contracts to provide COVAX with 200 …

Corbevax Samples Cleared by Kasauli Lab, Paving Way for Stockpiling, Vaccine May Hit Market in December
3 years, 2 months ago

Corbevax Samples Cleared by Kasauli Lab, Paving Way for Stockpiling, Vaccine May Hit Market in December

News 18  

A batch of Hyderabad-based pharmaceutical firm Biological E’s Covid vaccine Corbevax has been cleared by the country’s apex testing laboratory in Himachal Pradesh, paving the way for the manufacturer to start stockpiling, News18.com has learnt. The Central Drugs Laboratory in Kasauli on Tuesday cleared the first lot of Corbevax vaccine, which was sent for testing before Biological E can kickstart …

Could quality concerns over Novavax's Covid vaccine in US mount trouble for Covovax in India?
3 years, 2 months ago

Could quality concerns over Novavax's Covid vaccine in US mount trouble for Covovax in India?

India Today  

Novavax is struggling to secure an emergency use authorisation from the United States Food And Drug Administration for its Covid-19 vaccine as questions have been raised over its rushed manufacturing and quality standards by the US drug regulator. With Novavax facing hurdles in proving it can manufacture its Covid-19 vaccine that meets regulator’s quality standards, the launch of Covovax in …

Serum Institute seeks DCGI nod for Covid vaccine Covovax
3 years, 2 months ago

Serum Institute seeks DCGI nod for Covid vaccine Covovax

India Today  

The Serum Institute of India on Friday sought permission from the Drugs Controller General of India to manufacture Covid-19 vaccine Covovax for restricted use in emergency situations at its Manjari manufacturing site, official sources said. There were no safety concerns arising from the study data and Covovax is safe and immunogenic in the adult population, Prakash Kumar Singh, Director, Government …

African Union to buy up to 110 million Moderna COVID vaccines
3 years, 2 months ago

African Union to buy up to 110 million Moderna COVID vaccines

Al Jazeera  

Arrangement brokered in part by the White House which will defer delivery of some doses intended for US to facilitate the deal. The African Union intends to buy up to 110 million doses of COVID-19 vaccines from Moderna Inc in an arrangement brokered in part by the White House which will defer delivery of some doses intended for the United …

Awaiting Govt Nod on Exports, Won't Rush Vaccine for Kids: Adar Poonawalla - News18
3 years, 2 months ago

Awaiting Govt Nod on Exports, Won't Rush Vaccine for Kids: Adar Poonawalla - News18

News 18  

Pune-based Serum Institute of India could export 2 to 3 crore Covid-19 vaccine doses to WHO-backed COVAX by November and December, the company’s chief Adar Poonawalla told News18.com. The manufacturer of Covishield, the vaccine which became the backbone of India’s vaccination drive against Covid-19, SII has boosted its production capacity to 22 crore doses per month. “That said, based on …

India May Speed Up Covid-19 Vaccine Exports Under Maitri Programme By December
3 years, 2 months ago

India May Speed Up Covid-19 Vaccine Exports Under Maitri Programme By December

News 18  

Anticipating excess stock of Covid-19 vaccines, India may accelerate the export under its humanitarian initiative — Vaccine Maitri — by December, News18.com has learnt. “As soon as we will get into a situation where we will have vaccine stock more than the requirement of Indian population, we will accelerate the exports to serve the requirement of other nations,” a senior …

Discover Related